Search

everythinglearnresearchcommunity

for

Search:↓

YWS1903 is safe for pregnant rats at moderate doses but causes fetal issues at high doses.

JAK inhibitors like tofacitinib may effectively treat alopecia in children without major side effects.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Radiation from a medical procedure caused temporary hair loss, but hair regrew with treatment.

A patient with complete hair loss regrew all her hair using tofacitinib.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

The ZMY-1 system makes hair transplants faster without losing safety or effectiveness.

Tofacitinib helped a woman regrow hair with no major side effects.

ITK inhibitors may effectively treat alopecia areata.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

New punch designs for hair transplants have expanded options for surgeons.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

Tofacitinib is an effective and safe treatment for alopecia areata.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Tofacitinib effectively improved hair regrowth and skin condition in a woman with alopecia totalis and lichen planus hypertrophicus.

TGF-β2 helps yak hair follicles enter the regression phase, while HSP70 tries to prevent it.

Tazarotene gel is more effective for acne than tretinoin and works as well as adapalene.

YH0618 helps reduce chemotherapy-induced hair loss by targeting specific proteins and pathways.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Tofacitinib effectively treats severe alopecia areata, improving hair regrowth and patient satisfaction.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Tofacitinib is effective and safe for treating alopecia areata.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Oral betamethasone works faster than oral tofacitinib for hair regrowth in alopecia areata.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.